These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1663775

  • 1. Human leukocyte interferon alpha (HLI-alpha) for treatment of pleural effusion caused by non small cell lung cancer. A pilot study.
    Tercelj-Zorman M, Mermolja M, Jereb M, Oman M, Soos E, Petric-Grabnar G, Jereb B.
    Acta Oncol; 1991; 30(8):963-5. PubMed ID: 1663775
    [Abstract] [Full Text] [Related]

  • 2. Intrapleural application of human leukocyte interferon (HLI) in breast cancer patients with ipsilateral pleural carcinomatosis.
    Jereb B, Us-Krasovec M, Cervek J, Soos E.
    J Interferon Res; 1987 Aug; 7(4):357-63. PubMed ID: 3668305
    [Abstract] [Full Text] [Related]

  • 3. Presence of dendritic cells in malignant pleural effusion: pilot study.
    Surdacka A, Krawczyk P, Dańko M, Jastrzebska I, Milanowski J, Roliński J.
    Ann Univ Mariae Curie Sklodowska Med; 2003 Aug; 58(1):204-10. PubMed ID: 15314985
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intrapleural natural beta interferon in the treatment of malignant pleural effusions.
    Rosso R, Rimoldi R, Salvati F, De Palma M, Cinquegrana A, Nicolò G, Ardizzoni A, Fusco U, Capaccio A, Centofanti R.
    Oncology; 1988 Aug; 45(3):253-6. PubMed ID: 2453008
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
    Kim BS, Kim IJ, Kim SJ, Pak K, Kim K.
    Onkologie; 2011 Aug; 34(6):298-303. PubMed ID: 21625182
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected.
    Ren Y, Dai C, Shen J, Liu Y, Xie D, Zheng H, He J, Liang W, Jiang G, Fei K, Yang P, He J, Chen C.
    Oncotarget; 2016 May 03; 7(18):26856-65. PubMed ID: 27057627
    [Abstract] [Full Text] [Related]

  • 15. Pleural fluid neuron-specific enolase. A useful diagnostic marker for small cell lung cancer pleurisy.
    Shimokata K, Niwa Y, Yamamoto M, Sasou H, Morishita M.
    Chest; 1989 Mar 03; 95(3):602-3. PubMed ID: 2537710
    [Abstract] [Full Text] [Related]

  • 16. Pleural effusion as a significant prognostic factor in non-small cell lung cancer.
    Naito T, Satoh H, Ishikawa H, Yamashita YT, Kamma H, Takahashi H, Ohtsuka M, Hasegawa S.
    Anticancer Res; 1997 Mar 03; 17(6D):4743-6. PubMed ID: 9494600
    [Abstract] [Full Text] [Related]

  • 17. Primary tumour resection showed survival benefits for non-small-cell lung cancers with unexpected malignant pleural dissemination.
    Ren YJ, She YL, Dai CY, Jiang GN, Fei K, Chen C.
    Interact Cardiovasc Thorac Surg; 2016 Mar 03; 22(3):321-6. PubMed ID: 26705302
    [Abstract] [Full Text] [Related]

  • 18. Effects of a simple intraoperative intrathoracic hyperthermotherapy for lung cancer with malignant pleural effusion or dissemination.
    Kimura M, Tojo T, Naito H, Nagata Y, Kawai N, Taniguchi S.
    Interact Cardiovasc Thorac Surg; 2010 Apr 03; 10(4):568-71. PubMed ID: 20093263
    [Abstract] [Full Text] [Related]

  • 19. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial.
    Luh KT, Yang PC, Kuo SH, Chang DB, Yu CJ, Lee LN.
    Cancer; 1992 Feb 01; 69(3):674-9. PubMed ID: 1309678
    [Abstract] [Full Text] [Related]

  • 20. Symptomatic treatment of recurrent malignant pleural effusions with intrapleurally administered Corynebacterium parvum. Clinical response is not associated with evidence of enhancement of local cellular-mediated immunity.
    Rossi GA, Felletti R, Balbi B, Sacco O, Cosulich E, Risso A, Melioli G, Ravazzoni C.
    Am Rev Respir Dis; 1987 Apr 01; 135(4):885-90. PubMed ID: 2436513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.